Immunic, Inc. (IMUX)Healthcare | Biotechnology | New York, United States | NasdaqCM
15.40 USD
-0.90
(-5.521%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 15.40 |
Hot Take ↕ | Aug. 22, 2026, 5:14 a.m. EDT
The investment case here is fundamentally broken. The company has endured five consecutive years of negative annual returns, with the stock losing 99.6% of its value over the last nine years. This is not a temporary setback; it is a structural implosion where the market has repeatedly rejected the business model. Despite a 'strong buy' analyst recommendation and a lofty $85 target price, these metrics are irrelevant when the underlying economics show negative returns on assets and equity, and the stock trades at a premium to book value despite having no earnings. The recent 1-for-10 reverse split is a classic hallmark of a dying stock trying to prop up its price per share. With no dividend to provide income and a balance sheet showing significant cash burn, the long-term outlook is bleak. Short-term, the heavy put writing indicates that smart money expects further deterioration, making any bounce a potential trap for late buyers. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.062421 |
| AutoARIMA | 0.062422 |
| MSTL | 0.078132 |
| AutoTheta | 0.128569 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 32% |
| H-stat | 0.37 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.001 |
| Excess Kurtosis | 1.08 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.444 |
| Market Cap | 210,124,784 |
| Forward P/E | -6.15 |
| Beta | 1.40 |
| Website | https://imux.com |
As of Aug. 22, 2026, 5:14 a.m. EDT: Speculators are positioning heavily for downside protection, evidenced by massive open interest in out-of-the-money puts (strikes at $1.00 and $12.50) compared to negligible call volume. While there is some call activity at higher strikes ($25.00), the overwhelming volume in deep OTM puts suggests a fear of a significant collapse rather than a bullish bet on recovery.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.04005 |
| Address1 | 1,200 Avenue of the Americas |
| Address2 | Suite 200 |
| All Time High | 14,080.0 |
| All Time Low | 5.06 |
| Ask | 19.62 |
| Ask Size | 2 |
| Audit Risk | 8 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 177,290 |
| Average Daily Volume3 Month | 183,758 |
| Average Volume | 183,758 |
| Average Volume10Days | 177,290 |
| Beta | 1.398 |
| Bid | 11.67 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | 9.35 |
| City | New York |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 15.4 |
| Current Ratio | 5.049 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 16.3 |
| Day Low | 15.05 |
| Debt To Equity | 0.444 |
| Display Name | Immunic |
| Dividend Date | 1,555,286,400 |
| Earnings Call Timestamp End | 1,730,984,400 |
| Earnings Call Timestamp Start | 1,730,984,400 |
| Earnings Timestamp | 1,786,451,400 |
| Earnings Timestamp End | 1,794,486,600 |
| Earnings Timestamp Start | 1,794,486,600 |
| Ebitda | -117,733,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.472 |
| Enterprise Value | 55,593,792 |
| Eps Current Year | -3.68727 |
| Eps Forward | -2.506 |
| Eps Trailing Twelve Months | -3.35 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 15.0148 |
| Fifty Day Average Change | 0.38519955 |
| Fifty Day Average Change Percent | 0.025654657 |
| Fifty Two Week Change Percent | 104.005005 |
| Fifty Two Week High | 17.43 |
| Fifty Two Week High Change | -2.0300007 |
| Fifty Two Week High Change Percent | -0.116465904 |
| Fifty Two Week Low | 5.06 |
| Fifty Two Week Low Change | 10.34 |
| Fifty Two Week Low Change Percent | 2.0434783 |
| Fifty Two Week Range | 5.06 - 17.43 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,397,741,400,000 |
| Float Shares | 11,918,169 |
| Forward Eps | -2.506 |
| Forward P E | -6.1452513 |
| Free Cashflow | -51,407,248 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 100 |
| Fullday Change | -0.9 |
| Fullday Change Percent | -5.52147 |
| Fullday Price | 15.4 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00971 |
| Held Percent Institutions | 0.65115 |
| Implied Shares Outstanding | 13,644,467 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,777,248,000 |
| Last Split Factor | 1:10 |
| Long Business Summary | Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company also develops IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York. |
| Long Name | Immunic, Inc. |
| Market | us_market |
| Market Cap | 210,124,784 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_403013221 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -111,566,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 222,404,812 |
| Number Of Analyst Opinions | 11 |
| Open | 16.21 |
| Operating Cashflow | -87,720,000 |
| Operating Margins | 0.0 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 332 255 9818 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 15.4 |
| Post Market Time | 1,787,959,805 |
| Previous Close | 16.3 |
| Price Eps Current Year | -4.176532 |
| Price Hint | 2 |
| Price To Book | 1.6470587 |
| Profit Margins | 0.0 |
| Quick Ratio | 4.971 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.9 |
| Regular Market Change Percent | -5.52147 |
| Regular Market Day High | 16.3 |
| Regular Market Day Low | 15.0 |
| Regular Market Day Range | 15.0 - 16.3 |
| Regular Market Open | 16.21 |
| Regular Market Previous Close | 16.3 |
| Regular Market Price | 15.4 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 357,905 |
| Return On Assets | -0.66796994 |
| Return On Equity | -1.38169 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 13,644,467 |
| Shares Percent Shares Out | 0.0936 |
| Shares Short | 1,277,166 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 1,413,871 |
| Short Name | Immunic, Inc. |
| Short Percent Of Float | 0.099 |
| Short Ratio | 7.96 |
| Source Interval | 15 |
| State | NY |
| Symbol | IMUX |
| Target High Price | 85.0 |
| Target Low Price | 19.0 |
| Target Mean Price | 42.18182 |
| Target Median Price | 30.0 |
| Total Cash | 155,098,000 |
| Total Cash Per Share | 11.367 |
| Total Debt | 567,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.35 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 10.820725 |
| Two Hundred Day Average Change | 4.579274 |
| Two Hundred Day Average Change Percent | 0.42319474 |
| Type Disp | Equity |
| Volume | 357,905 |
| Website | https://imux.com |
| Zip | 10,036 |